GPR182 is a lipoprotein receptor for dietary fat absorption

Area of Science:

• Lipid metabolism
• Lymphatic system physiology
• Gastrointestinal absorption

Background:

• The lymphatic system transports dietary lipids via chylomicrons (CMs).
• The precise molecular mechanisms of CM entry into intestinal lymphatics remain unclear.
• Understanding this process is key to addressing lipid absorption disorders and obesity.

Purpose of the Study:

• To identify the molecular receptor responsible for chylomicron uptake in intestinal lymphatics.
• To investigate the role of GPR182 in dietary fat absorption and lipid metabolism.
• To evaluate GPR182 as a potential therapeutic target for obesity.

Main Methods:

• Utilized GPR182 knockout mouse models.
• Performed lipid absorption assays and metabolic studies.
• Employed transmission electron microscopy to visualize CM transport.
• Tested the efficacy of GPR182 blockade using monoclonal antibodies.

Main Results:

• GPR182 knockout mice showed impaired lipid absorption and delayed growth.
• These mice exhibited increased high-density lipoproteins and resistance to diet-induced obesity.
• GPR182 was identified as a receptor mediating lipoprotein and CM transport into lymphatics.
• Antibody-mediated GPR182 blockade protected against and treated obesity in mice.

Conclusions:

• GPR182 is a critical mediator of dietary fat absorption by facilitating chylomicron entry into intestinal lymphatics.
• GPR182 functions as a lipoprotein receptor involved in lipid transport.
• Targeting GPR182 with blockade strategies offers a promising therapeutic avenue for managing obesity and related metabolic conditions.